Literature DB >> 19436787

Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.

José-Luis E Velazquez-Ceceña1, David L Lubell, Nagapradeep Nagajothi, Hytham Al-Masri, Mumtaz Siddiqui, Sandeep Khosla.   

Abstract

Dynamic left ventricular outflow tract (LVOT) obstruction is seen classically in hypertrophic cardiomyopathy. Cardiac amyloidosis can present with asymmetric hypertrophy that resembles hypertrophic cardiomyopathy, and, in some cases, with dynamic LVOT obstruction. The occurrence of syncope in such patients is not uncommon. The syncope is usually thought to be related to mechanisms other than LVOT obstruction, such as arrhythmias, conduction disturbances, orthostatic hypotension, or vasovagal effects associated with neuropathy.Herein, we report the case of a patient who had immunocyte-derived (primary AL-type) cardiac amyloidosis with the echocardiographic appearance of hypertrophic cardiomyopathy and evidence of LVOT obstruction that caused syncope. We were able to provoke and identify dynamic LVOT obstruction that produced presyncopal symptoms similar to those that typically occur in such patients spontaneously. Dynamic LVOT obstruction as a cause of syncope should be considered in patients who have cardiac amyloidosis and echocardiographic evidence of hypertrophic cardiomyopathy.

Entities:  

Keywords:  Amyloidosis/classification/diagnosis/etiology/mortality/pathology/therapy; cardiomyopathies/complications/diagnosis; cardiomyopathy, hypertrophic/diagnosis; diagnosis, differential; echocardiography; heart failure/etiology; prognosis; syncope/etiology/physiopathology; ventricular outflow obstruction/etiology

Mesh:

Year:  2009        PMID: 19436787      PMCID: PMC2676515     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  20 in total

1.  Amyloid heart disease mimicking hypertrophic cardiomyopathy.

Authors:  S Mörner; U Hellman; O B Suhr; E Kazzam; A Waldenström
Journal:  J Intern Med       Date:  2005-09       Impact factor: 8.989

Review 2.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

Review 3.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

4.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

5.  The premortem recognition of systemic senile amyloidosis with cardiac involvement.

Authors:  R A Kyle; P C Spittell; M A Gertz; C Y Li; W D Edwards; L J Olson; S N Thibodeau
Journal:  Am J Med       Date:  1996-10       Impact factor: 4.965

6.  The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement.

Authors:  S W Dubrey; K Cha; J Anderson; B Chamarthi; J Reisinger; M Skinner; R H Falk
Journal:  QJM       Date:  1998-02

7.  Cardiac amyloidosis mimicking the echocardiographic appearance of obstructive hypertrophic myopathy.

Authors:  C F Presti; B F Waller; W F Armstrong
Journal:  Chest       Date:  1988-04       Impact factor: 9.410

8.  Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis.

Authors:  B Chamarthi; S W Dubrey; K Cha; M Skinner; R H Falk
Journal:  Am J Cardiol       Date:  1997-11-01       Impact factor: 2.778

9.  Dynamic left ventricular outflow tract obstruction in senile cardiac amyloidosis.

Authors:  Farouk Mookadam; John H Haley; Lyle J Olson; Maja Cikes; Martina Mookadam
Journal:  Eur J Echocardiogr       Date:  2005-10-19

10.  Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry.

Authors:  L J Olson; M A Gertz; W D Edwards; C Y Li; P A Pellikka; D R Holmes; A J Tajik; R A Kyle
Journal:  N Engl J Med       Date:  1987-09-17       Impact factor: 91.245

View more
  4 in total

1.  Coexistence of cardiac amyloidosis with coronary artery disease and the challenges in medical management.

Authors:  Vasvi Singh; Alexander Tiemeier; Saurabh Malhotra
Journal:  J Nucl Cardiol       Date:  2019-02-20       Impact factor: 5.952

2.  Syncope in cardiac amyloidosis and chronic ischemic heart disease: A case report.

Authors:  Giacomo Mugnai; Mariantonietta Cicoira; Andrea Rossi; Corrado Vassanelli
Journal:  Exp Clin Cardiol       Date:  2011

3.  Updates in cardiac amyloidosis: a review.

Authors:  Sanjay M Banypersad; James C Moon; Carol Whelan; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  J Am Heart Assoc       Date:  2012-04-24       Impact factor: 5.501

4.  Cardiac amyloidosis: The great masquerader.

Authors:  Jubran Rind; Nagib Chalfoun; Richard McNamara
Journal:  Glob Cardiol Sci Pract       Date:  2018-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.